MedTrace Logo

Simethicone and Bowel Preparation in Colonoscopy

NCT03157791 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 471

Last updated 2018-05-23

No results posted yet for this study

Summary

This Clinical Trial is being conducted to study the effect of oral simethicone on the presence of bubbles during colonoscopy. The purpose of this study is to find out what effects (good and bad) the addition of oral simethicone to bowel preparation has on the ability to visualize the colon mucosa (bowel) during colonoscopy.

Conditions

  • Colonoscopy
  • Bowel Preparation

Interventions

DRUG

Simethicone 180Mg Cap

Simethicone Group A will take a total of 360mg prior to colonoscopy of Simethicone 180Mg Cap.

Sponsors & Collaborators

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Melissa Towle, RN · Brandon Regional Health Centre

  • Charlenn Skead, BA · University of Manitoba

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-05
Primary Completion
2017-11-26
Completion
2017-11-26

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03157791 on ClinicalTrials.gov